Skip to main content
Premium Trial:

Request an Annual Quote

UC and Springer Nature Reach Deal

The University of California and scientific publisher Springer Nature have reached a deal on open-access publishing.

Under a four-year agreement, UC research published in Springer Nature journals will be open access, and UC students, faculty, and researchers will have access to more than 1,000 Springer Nature journals, including ones to which UC did not previously subscribe. At the same time, UC and Springer Nature are to launch an open science pilot project. 

According to the Financial Times, this is the largest open-access agreement in North America. It adds that how much UC will pay will depend on the number of articles published, but that the university system estimates that it will bring down its costs.

"UC has always believed that providing greater open access to knowledge is the right thing to do. Springer Nature showed us that it can be done," Jeffrey MacKie-Mason, a librarian and economics professor at UC Berkeley who co-chaired the publisher negotiation team, says in a statement.

Last year, the University of California ended its subscription contract negiotiations with Elsevier, as it sought a "read-and-publish" contract that combined journal subscription and open-access publishing fees, but Elsevier wanted to maintain its traditional contract. MIT last week similarly ended negotiations with Elsevier.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.